Thymidylate Synthase: A Target for Combination Therapy and Determinant of Chemotherapeutic Response in Colorectal Cancer

Thymidylate Synthase: A Target for Combination Therapy and Determinant of Chemotherapeutic Response in Colorectal Cancer
复制标题

胸苷酸合成酶:结直肠癌联合治疗的靶点和化疗反应的决定因素

DOI:
--
复制
发表时间:
1999
期刊:
影响因子:
3.5
通讯作者:
G. Peters
G. Peters
中科院分区:
医学3区
文献类型:
--
作者:
B. van Triest;G. Peters

文献摘要

参考文献

被引文献

相似文献

在这篇综述中,我们描述了胸苷酸合成酶(TS)作为化疗反应的决定因素的作用。TS是胸苷酸从头合成和随后的DNA合成的必需酶。TS已被用作癌症化疗的靶点,用于开发氟嘧啶类药物,如5-氟尿嘧啶(5 FU)和5-氟脱氧尿苷,以及新型叶酸基TS抑制剂,如ZD 1694(Tomudex,雷替曲塞)、LY 231514、AG 337(Thymitaq)和GW 1843 U89。所有这些抗叶酸剂具有不同的转运机制和各种多聚谷氨酰化和积累模式,这些对于药物敏感性都很重要。将提供TS抑制剂临床研究的更新(基于抗叶酸剂的TS抑制剂和5 FU联合研究),并将讨论临床开发的新观点。TS的预后或预测价值(体外,体内和患者)将审查,重点是结直肠癌。
In this review, we describe the role of thymidylate synthase (TS) as a determinant of chemotherapeutic response. TS is an essential enzyme for the de novo synthesis of thymidylate and subsequent DNA synthesis. TS has been used as a target for cancer chemotherapy in the development of fluoropyrimidines such as 5-fluorouracil (5FU) and 5-fluorodeoxyuridine and novel folate-based TS inhibitors such as ZD1694 (Tomudex, Raltitrexed), LY231514, AG337 (Thymitaq) and GW1843U89. All these antifolates have different transport mechanisms and various polyglutamylation and accumulation patterns which are all important for drug sensitivity. An update of clinical studies with TS inhibitors (antifolate-based TS inhibitors and 5FU combination studies) will be given and new perspectives for clinical development will be discussed. The prognostic or predictive value of TS (in vitro, in vivo and in patients) will be reviewed, focusing on colorectal cancer.
DOI: --
发表时间: 1994-04
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者:
J. Wurzer;R. Tallarida;M. Sirover
通讯作者: J. Wurzer;R. Tallarida;M. Sirover
DOI: 10.1016/s0021-9258(18)82448-6
发表时间: 1993-07
期刊: The Journal of biological chemistry
影响因子: --
作者:
K. Keyomarsi;Jonathan M. Samet;Gyongyi Molnar;A. Pardee
通讯作者: K. Keyomarsi;Jonathan M. Samet;Gyongyi Molnar;A. Pardee
DOI: 10.1126/science.1905840
发表时间: 1991-07-05
期刊: SCIENCE
影响因子: 56.9
作者:
HOLLSTEIN, M;SIDRANSKY, D;HARRIS, CC
通讯作者: HARRIS, CC
DOI: --
发表时间: 1998-05
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
H. Lenz;K. Hayashi;D. Salonga;K. Danenberg;P. Danenberg;R. Metzger;D. Banerjee;J. Bertino;S. Groshen;L. Leichman;C. Leichman
通讯作者: H. Lenz;K. Hayashi;D. Salonga;K. Danenberg;P. Danenberg;R. Metzger;D. Banerjee;J. Bertino;S. Groshen;L. Leichman;C. Leichman
DOI: 10.1200/jco.1997.15.10.3223
发表时间: 1997-10-01
影响因子: 45.3
作者:
Leichman, CG;Lenz, HJ;Danenberg, PV
通讯作者: Danenberg, PV